# 510k Summary K121012

<table><tr><td rowspan=1 colspan=1>Submitter&#x27;s name/address</td><td rowspan=1 colspan=1>Inpeco S.p.A.Via Giuseppe di Vittorio 1120090 Segrate, Milan, Italy</td></tr><tr><td rowspan=1 colspan=1>Primary Contact Person</td><td rowspan=1 colspan=1>Roberto TamborraRegulatory Affairs Managerroberto.tamborra@inpeco.comPhone number: +39 02 36681263Mobile Phone number +39 334 6669384</td></tr><tr><td rowspan=1 colspan=1>Secondary Contact Person</td><td rowspan=1 colspan=1>Luisa MellaRegulatory Affairs Specialistluisa.mella@inpeco.comPhone number: +39 02 36681316</td></tr><tr><td rowspan=1 colspan=1>Date of preparation of thisSummary:</td><td rowspan=1 colspan=1>2012-03-30</td></tr><tr><td rowspan=1 colspan=1>Device Trade or ProprietaryName:</td><td rowspan=1 colspan=1>FlexLab 3.6ACCELERATOR a3600</td></tr><tr><td rowspan=1 colspan=1>Device Common Name:</td><td rowspan=1 colspan=1>Laboratory Automation</td></tr><tr><td rowspan=1 colspan=1>Classification Number/Class:</td><td rowspan=1 colspan=1>JQP, Class I (FlexLab 3.6 andACCELERATOR a3600)JJE, Class I (ARCHITECT)JGS, CEM, CGZ, Class II (Sodium,Potassium, Chloride)</td></tr></table>

Please consider that FlexLab 3.6 and ACCELERATOR a3600 are exactly the same product, the only difference is in the brand name.

In the annexes sometimes only FlexLab 3.6 brand name is listed but all the documents are valid also for ACCELERATOR a3600 brand name. This happens because internally the project was developed under FlexLab 3.6 brand name and then the product will be sold with two different brand names: FlexLab 3.6 and ACCELERATOR a3600.

# ${ \bar { \bf 5 1 0 } } ( { \bf k } )$ Summary

This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of the SMDA 1990 and 21 CFR 807.92.

The assigned 510(k) number is: _k121012_

# Identification of Predicate Device:

<table><tr><td rowspan=1 colspan=1>Predicate Instrument orAssay</td><td rowspan=1 colspan=1>510(k) Number</td><td rowspan=1 colspan=1>Product Code</td></tr><tr><td rowspan=1 colspan=1>APS Accelerator    </td><td rowspan=1 colspan=1>K093318</td><td rowspan=1 colspan=1>JQP</td></tr></table>

# Description:

The following is a brief description of the FlexLab 3.6 system.

The FlexLab 3.6 Automation is a modular system designed to automate Pre-Analytical and Post-Analytical processing, sample handling in order to automate sample processing in the Laboratory.

The system consolidates multiple Analytical instruments into a unified workstation.

The Automation software provides for workload management, sample routing to relevant Analytical instrument based on sample orders coming from LIS (Laboratory Information System) and instrument operational status monitoring. This is accomplished through communication connections between the Automation, Analytical instruments and LIS (Laboratory Information System) or middleware.

Pre-Analytical and Post-Analytical processing in details are as follows: sample loading and unloading and sample identification, sample transport along the system and routing to relevant modules, loading and unloading in centrifuge, decapping, sealing, desealing, storing in a temperature controlled environment, aliquoting, aliquot samples capping, sample presentation to connected Analytical instruments.

The FlexLab 3.6 Automation Systems perform the following pre and post analytical functions:

Sample bar code identification (previously performed by the analyzer)   
Sample transport and tracking   
Sample centrifugation (Optional functionality)   
Sample de-capping (Optional functionality)   
Sample re-capping (Optional functionality)   
Sample sealing (Optional functionality)   
Sample de-sealing (Optional functionality)   
Sample aliquoting (Optional functionality)   
Sample Storage and Retrieval (Optional functionality)

# Intended Use:

The FlexLab 3.6 Automation is a modular system designed to automate PreAnalytical and Post-Analytical processing, sample handling in order to automate sample processing in the Laboratory.

The system consolidates analytical instruments, such as the ARCHITECT c8000 System into a unified workstation that performs a variety of instrument specific assays such as Sodium, Potassium and Chloride.

Sodium, Potassium and Chloride measurements are used in the diagnosis and treatment of diseases involving electrolyte imbalance.

# Substantial Equivalence:

The substantial equivalence is demonstrated through a Method Comparison Study between an ARCHITECT $\mathbf { c 8 0 0 0 }$ analyzer integrated to the FlexLab 3.6system, and an ARCHITECT c8000 analyzer integrated to an ACCELERATOR APS utilizing the same specimens uniquely labeled with individual sample tube barcode labels for sample identification (SID).

The substantial equivalence testing is conducted utilizing the ARCHITECT c8000 ICT Module for the electrolytes of Sodium, Potassium and Chloride.

The FlexLab 3.6, as an accessory to the analyzers, does not change, expand, or limit the intended use of each analyzer product.

Table 5-1: Similarities and Difference Table to Predicate Devices   

<table><tr><td colspan="1" rowspan="1">ProductFunctionality</td><td colspan="1" rowspan="1">Predicate Device:ARCHITECT c8000 withembedded ICT Moduleintegrated toACCELERATOR APS</td><td colspan="1" rowspan="1">Test Device:ARCHITECT c8000 withembedded ICT Moduleintegrated to FlexLab 3.6</td></tr><tr><td colspan="1" rowspan="1">Intended Use</td><td colspan="1" rowspan="1">Same, with automated pre-analytical sample processingand transporting to theARCHITECT analyzer</td><td colspan="1" rowspan="1">Same, with automated pre-analytical sample processingand transporting to theARCHITECT analyzer</td></tr><tr><td colspan="1" rowspan="1">Principle ofOperation</td><td colspan="1" rowspan="1">Same</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Sample Containers</td><td colspan="1" rowspan="1">Primary or Aliquot Tubes</td><td colspan="1" rowspan="1">Primary and secondary Tubes</td></tr><tr><td colspan="1" rowspan="1">Sample Aspiration</td><td colspan="1" rowspan="1">Directly from primary tubepresented to the aspirationpoint by the ACCELERATORAPS track or spur</td><td colspan="1" rowspan="1">Directly from primary tubepresented to the aspirationpoint by the FlexLab 3.6 trackor spur</td></tr><tr><td colspan="1" rowspan="1">Sample Handling</td><td colspan="1" rowspan="1">Directly loaded into theARCHITECT via the LSH orvia ACCELERATOR APS</td><td colspan="1" rowspan="1">Directly loaded into theARCHITECT via the LSH orvia FlexLab 3.6</td></tr><tr><td colspan="1" rowspan="5">Sample Pre-Analytics(centrifuge, de-cap, re-seal, re-cap,aliquoter)</td><td colspan="1" rowspan="1">Manually centrifuged sampletubes by laboratory personnelor automatically centrifugedtubes by ACCELERATORAPS</td><td colspan="1" rowspan="1">Manually centrifuged sampletubes by laboratory personnelor automatically centrifugedtubes by FlexLab 3.6</td></tr><tr><td colspan="1" rowspan="1">Manually de-capped sampletubes by laboratory personnelor automatically de-cappedtubes by ACCELERATORAPS</td><td colspan="1" rowspan="1">Manually de-capped sampletubes by laboratory personnelor automatically de-cappedtubes by FlexLab 3.6</td></tr><tr><td colspan="1" rowspan="1">Manually re-sealed sampletubes by laboratory personnelor automatically re-sealedtubes by ACCELERATORAPS</td><td colspan="1" rowspan="1">Manually re-sealed sampletubes by laboratory personnelor automatically re-sealedtubes by FlexLab 3.6</td></tr><tr><td colspan="1" rowspan="1">Manually aliquoted samples bylaboratory personnel orautomatically aliquoted tubesby ACCELERATOR APS</td><td colspan="1" rowspan="1">Manually aliquoted samples bylaboratory personnel orautomatically aliquoted tubesby</td></tr><tr><td colspan="1" rowspan="1">Same</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">SampleTransportation</td><td colspan="1" rowspan="1">External to analyzer: byACCELERATOR APStransport carriers identified onthe system by RFID tags.Internal to analyzer: N/A,samples presented to analyzervia ACCELERATOR a3600for aspiration.</td><td colspan="1" rowspan="1">External to analyzer: byFlexLab 3.6 transport carriersidentified on the system byRFID tags.Internal to analyzer: N/A,samples presented to analyzervia FlexLab 3.6 for aspiration.</td></tr><tr><td colspan="1" rowspan="1">SampleIdentification frombar coded tubes</td><td colspan="1" rowspan="1">Bar coded sample tubes readdirectly by analyzer whenplaced on LSH, or sample barcode read by ACCELERATORAPS and electronicallytransferred to the ARCHITECTc8000 analyzer when presentedat the aspiration point</td><td colspan="1" rowspan="1">Bar coded sample tubes readdirectly by analyzer whenplaced on LSH, or sample barcode read by FlexLab 3.6 andelectronically transferred to theARCHITECT c8000 analyzerwhen presented at theaspiration point</td></tr><tr><td colspan="1" rowspan="1">SampleStorage/Retrieval</td><td colspan="1" rowspan="1">Manually stored and retrievedby laboratory personnel orautomatically stored/retrievedby ACCELERATOR APS</td><td colspan="1" rowspan="1">Manually stored and retrievedby laboratory personnel orautomatically stored/retrievedby FlexLab 3.6</td></tr><tr><td colspan="1" rowspan="1">Test Orders</td><td colspan="1" rowspan="1">Same</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Test Results</td><td colspan="1" rowspan="1">Same</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">LASCommunication</td><td colspan="1" rowspan="1">ARCHITECT softwarecommunicates withACCELERATOR APS viaLAS interface</td><td colspan="1" rowspan="1">ARCHITECT softwarecommunicates with FlexLab3.6 via LAS interface</td></tr><tr><td colspan="1" rowspan="1">LISCommunication</td><td colspan="1" rowspan="1">ARCHITECT softwarecommunicates with hospitalLIS via ACCELERATOR APSdata management systeminterface</td><td colspan="1" rowspan="1">ARCHITECT softwarecommunicates with hospitalLIS via FlexLab 3.6 datamanagement system interface</td></tr></table>

# Performance Characteristics:

The method correlation comparison study was conducted between:

• an ARCHITECT c8000 analyzer integrated with the FlexLab 3.6 system and an ARCHITECT c8000 analyzer integrated with the ACCELERATOR APS system

and yielded the following results for the Sodium, Potassium and Chloride assays:

# Chloride

# Method Comparison Data FlexLab 3.6 vs. ACCELERATOR APS 1st Replicate versus Mean - Chloride Assay - Linear Range

<table><tr><td rowspan=1 colspan=2>CI</td><td rowspan=1 colspan=4>Least Squares</td><td rowspan=1 colspan=4>Deming</td><td rowspan=1 colspan=4>Passing-Bablok</td><td rowspan=2 colspan=4>Blas / Total Error</td></tr><tr><td rowspan=2 colspan=1>N</td><td rowspan=2 colspan=1>.CorrCoef</td><td rowspan=1 colspan=2>Slope</td><td rowspan=1 colspan=2>Intercept</td><td rowspan=1 colspan=2>Slope</td><td rowspan=1 colspan=2>Intercept</td><td rowspan=1 colspan=2>Slope</td><td rowspan=1 colspan=2>Intercept</td></tr><tr><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>%95 CI</td><td rowspan=1 colspan=1>Int</td><td rowspan=1 colspan=1>95% CI</td><td rowspan=1 colspan=1>&#x27;Slope</td><td rowspan=1 colspan=1>%95 CI</td><td rowspan=1 colspan=1>•Int</td><td rowspan=1 colspan=1>95% CI</td><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>95% CI</td><td rowspan=1 colspan=1>Int</td><td rowspan=1 colspan=1>95% CI</td><td rowspan=1 colspan=1>MeanBias</td><td rowspan=1 colspan=1>Mean%Bias</td><td rowspan=1 colspan=1>SD ofMean% Bias</td><td rowspan=1 colspan=1>AbsoluteValueof%TotalError</td></tr><tr><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>0.9993</td><td rowspan=1 colspan=1>1.00</td><td rowspan=1 colspan=1>(0.99,1.01)</td><td rowspan=1 colspan=1>:0.90</td><td rowspan=1 colspan=1>(-1.70, -0.09)</td><td rowspan=1 colspan=1>1.00</td><td rowspan=1 colspan=1>(0.99,1.01)</td><td rowspan=1 colspan=1>:0.97</td><td rowspan=1 colspan=1>(-1.65,-0.29)</td><td rowspan=1 colspan=1>1.00</td><td rowspan=1 colspan=1>(0.99,1.01)</td><td rowspan=1 colspan=1>-0.89</td><td rowspan=1 colspan=1>(-1.61,-0.23)</td><td rowspan=1 colspan=1>-.0.81</td><td rowspan=1 colspan=1>-0.8</td><td rowspan=1 colspan=1>0.72</td><td rowspan=1 colspan=1>2.3</td></tr></table>

# Method Comparison Data FlexLab 3.6 vs. ACCELERATOR APS Mean versus Mean Chloride Assay - Linear Range

<table><tr><td rowspan=1 colspan=2>CI</td><td rowspan=1 colspan=4>Least Squares</td><td rowspan=1 colspan=4>Deming</td><td rowspan=1 colspan=4>Passing-Bablok</td><td rowspan=2 colspan=4>Blas / Total Error</td></tr><tr><td rowspan=2 colspan=1>N</td><td rowspan=2 colspan=1>CorrCoef</td><td rowspan=1 colspan=2>Slope</td><td rowspan=1 colspan=2>Intercept</td><td rowspan=1 colspan=2>Slope</td><td rowspan=1 colspan=2>Intercept</td><td rowspan=1 colspan=2>Slope</td><td rowspan=1 colspan=2>Intercept</td></tr><tr><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>%95 CI</td><td rowspan=1 colspan=1>Int</td><td rowspan=1 colspan=1>95% CI</td><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>%95 Cl</td><td rowspan=1 colspan=1>Int</td><td rowspan=1 colspan=1>95% CI</td><td rowspan=1 colspan=1>.Slope</td><td rowspan=1 colspan=1>95% CI</td><td rowspan=1 colspan=1>Int</td><td rowspan=1 colspan=1>95% CI</td><td rowspan=1 colspan=1>MeanBias</td><td rowspan=1 colspan=1>Mean%Bias</td><td rowspan=1 colspan=1>SD ofMean% Bias</td><td rowspan=1 colspan=1>AbsoluteValueof% TotalError</td></tr><tr><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>0.9997</td><td rowspan=1 colspan=1>1.00</td><td rowspan=1 colspan=1>(1.00,1.01)</td><td rowspan=1 colspan=1>-1.13</td><td rowspan=1 colspan=1>(-1.68, -0.58)</td><td rowspan=1 colspan=1>1.00</td><td rowspan=1 colspan=1>(1.00,1.01)</td><td rowspan=1 colspan=1>-1.17</td><td rowspan=1 colspan=1>(-1.74,-0.59)</td><td rowspan=1 colspan=1>1.00</td><td rowspan=1 colspan=1>(0.99,1.01)</td><td rowspan=1 colspan=1>-0.91</td><td rowspan=1 colspan=1>(-1.40, -0.28)</td><td rowspan=1 colspan=1>-0.85</td><td rowspan=1 colspan=1>-0.9</td><td rowspan=1 colspan=1>0.56</td><td rowspan=1 colspan=1>2.0</td></tr></table>

# Potassium

# Method Comparison Data FlexLab 3.6 vs. ACCELERATOR APS 1st Replicate versus Mean Potassium Assay - Linear Range

<table><tr><td rowspan=1 colspan=2>K</td><td rowspan=1 colspan=4>Least Squares</td><td rowspan=1 colspan=4>Deming</td><td rowspan=1 colspan=4>Passing-Bablok</td><td rowspan=2 colspan=4>Bias / Total Error</td></tr><tr><td rowspan=2 colspan=1>N</td><td rowspan=2 colspan=1>CorrCoef</td><td rowspan=1 colspan=2>Slope</td><td rowspan=1 colspan=2>Intercept</td><td rowspan=1 colspan=2>Slope</td><td rowspan=1 colspan=2>Intercept</td><td rowspan=1 colspan=2>Slope</td><td rowspan=1 colspan=2>Intercept</td></tr><tr><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>%95 CI</td><td rowspan=1 colspan=1>Int</td><td rowspan=1 colspan=1>95% CI</td><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>%95 CI</td><td rowspan=1 colspan=1>Int</td><td rowspan=1 colspan=1>95% CI</td><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>95% CI</td><td rowspan=1 colspan=1>Int</td><td rowspan=1 colspan=1>95% CI</td><td rowspan=1 colspan=1>MeanBias</td><td rowspan=1 colspan=1>Mean%Bias</td><td rowspan=1 colspan=1>SD ofMean% Bias</td><td rowspan=1 colspan=1>AbsoluteValueof%TotalError</td></tr><tr><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>0.9995</td><td rowspan=1 colspan=1>1.00</td><td rowspan=1 colspan=1>(1.00,1.01)</td><td rowspan=1 colspan=1>-0.06</td><td rowspan=1 colspan=1>(-0.09, -0.03)</td><td rowspan=1 colspan=1>1.00</td><td rowspan=1 colspan=1>(1.00,1.01)</td><td rowspan=1 colspan=1>-0.06</td><td rowspan=1 colspan=1>(-0.09, -0.03)</td><td rowspan=1 colspan=1>1.00</td><td rowspan=1 colspan=1>(1.00,1.01)</td><td rowspan=1 colspan=1>-0.05</td><td rowspan=1 colspan=1>(-0.07,-0.02)</td><td rowspan=1 colspan=1>-0.03</td><td rowspan=1 colspan=1>-0.8</td><td rowspan=1 colspan=1>1.11</td><td rowspan=1 colspan=1>3.0</td></tr></table>

# Method Comparison Data FlexLab 3.6 vs. ACCELERATOR APS Mean versus Mean Potassium Assay - Linear Range

<table><tr><td rowspan=1 colspan=2>K</td><td rowspan=1 colspan=4>Least Squares</td><td rowspan=1 colspan=4>Deming</td><td rowspan=1 colspan=4>Passing-Bablok</td><td rowspan=2 colspan=4>Bias / Total Error</td></tr><tr><td rowspan=2 colspan=1>N</td><td rowspan=2 colspan=1>CorrCoef</td><td rowspan=1 colspan=2>Slope</td><td rowspan=1 colspan=2>Intercept</td><td rowspan=1 colspan=2>Slope</td><td rowspan=1 colspan=2>Intercept</td><td rowspan=1 colspan=2>Slope</td><td rowspan=1 colspan=2>Intercept</td></tr><tr><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>%95 Cl</td><td rowspan=1 colspan=1>int</td><td rowspan=1 colspan=1>95% CI</td><td rowspan=1 colspan=1>Stope</td><td rowspan=1 colspan=1>%95 CI</td><td rowspan=1 colspan=1>Int</td><td rowspan=1 colspan=1>95% CI</td><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>95% CI</td><td rowspan=1 colspan=1>Int</td><td rowspan=1 colspan=1>95% Cl</td><td rowspan=1 colspan=1>MeanBias</td><td rowspan=1 colspan=1>Mean%Bias</td><td rowspan=1 colspan=1>SD ofMean% Blas</td><td rowspan=1 colspan=1>AbsoluteValueofxTotalError</td></tr><tr><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>0.9997</td><td rowspan=1 colspan=1>1.00</td><td rowspan=1 colspan=1>(1.00,1.01)</td><td rowspan=1 colspan=1>-0.06</td><td rowspan=1 colspan=1>(-0.08, -0.03)</td><td rowspan=1 colspan=1>1.00</td><td rowspan=1 colspan=1>(1.00,1.01)</td><td rowspan=1 colspan=1>-0.06</td><td rowspan=1 colspan=1>(-0.08, -0.03</td><td rowspan=1 colspan=1>1.00</td><td rowspan=1 colspan=1>(1.00,1.01)</td><td rowspan=1 colspan=1>-0.04</td><td rowspan=1 colspan=1>{-0.06, -0.02)</td><td rowspan=1 colspan=1>-0.04</td><td rowspan=1 colspan=1>.0.9</td><td rowspan=1 colspan=1>0.97</td><td rowspan=1 colspan=1>2.8</td></tr></table>

# Sodium

# Method Comparison Data FlexLab 3.6 vs. ACCELERATOR APS 1st Replicate versus Mean Sodium Assay $\cdot$ Linear Range

<table><tr><td rowspan=1 colspan=2>Na</td><td rowspan=1 colspan=4>Least Squares</td><td rowspan=1 colspan=4>Deming</td><td rowspan=1 colspan=4>Passing-Bablok</td><td rowspan=2 colspan=4>Bias / Total Error</td></tr><tr><td rowspan=2 colspan=1>N</td><td rowspan=2 colspan=1>CorrCoef</td><td rowspan=1 colspan=2>Slope</td><td rowspan=1 colspan=2>Intercept</td><td rowspan=1 colspan=2>Slope</td><td rowspan=1 colspan=2>Intercept</td><td rowspan=1 colspan=2>Slope</td><td rowspan=1 colspan=2>Intercept</td></tr><tr><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>%95 Cl</td><td rowspan=1 colspan=1>Int</td><td rowspan=1 colspan=1>95% Cl</td><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>%95 CI</td><td rowspan=1 colspan=1>Int</td><td rowspan=1 colspan=1>95% CI</td><td rowspan=1 colspan=1>Stope</td><td rowspan=1 colspan=1>95% CI</td><td rowspan=1 colspan=1>Int</td><td rowspan=1 colspan=1>.95% CI</td><td rowspan=1 colspan=1>MeanBias</td><td rowspan=1 colspan=1>Mean%Bias</td><td rowspan=1 colspan=1>SD ofMean% Bias</td><td rowspan=1 colspan=1>AbsoluteValueof%TotalError</td></tr><tr><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>0.9993</td><td rowspan=1 colspan=1>1.01</td><td rowspan=1 colspan=1>(1.00,1.02</td><td rowspan=1 colspan=1>-2.37</td><td rowspan=1 colspan=1>(-3.50,-1.25</td><td rowspan=1 colspan=1>1.01</td><td rowspan=1 colspan=1>{1.00,1.02)</td><td rowspan=1 colspan=1>.2.48</td><td rowspan=1 colspan=1>(-3.63, -1.33)</td><td rowspan=1 colspan=1>1.02</td><td rowspan=1 colspan=1>(1.01,1.03)</td><td rowspan=1 colspan=1>•3.08</td><td rowspan=1 colspan=1>(-4.72,-1.97)</td><td rowspan=1 colspan=1>.0.76</td><td rowspan=1 colspan=1>-0.6</td><td rowspan=1 colspan=1>0.90</td><td rowspan=1 colspan=1>2.4</td></tr></table>

# Method Comparison Data FlexLab 3.6 vs. ACCELERATOR APS Mean versus Mean Sodium Assay - Linear Range

<table><tr><td rowspan=1 colspan=2>Na</td><td rowspan=1 colspan=4>Least Squares</td><td rowspan=1 colspan=4>Deming</td><td rowspan=1 colspan=4>Passing-Bablok</td><td rowspan=2 colspan=4>&#x27;Bias / Total Error</td></tr><tr><td rowspan=2 colspan=1>N</td><td rowspan=2 colspan=1>CorrCoef</td><td rowspan=1 colspan=2>Slope</td><td rowspan=1 colspan=2>Intercept</td><td rowspan=1 colspan=2>Slope</td><td rowspan=1 colspan=2>Intercept</td><td rowspan=1 colspan=2>Slope</td><td rowspan=1 colspan=2>Intercept</td></tr><tr><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>%95 CI</td><td rowspan=1 colspan=1>Int</td><td rowspan=1 colspan=1>95% CI</td><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>%95 CI</td><td rowspan=1 colspan=1>Int</td><td rowspan=1 colspan=1>95% CI</td><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>95% CI</td><td rowspan=1 colspan=1>Int</td><td rowspan=1 colspan=1>95% CI</td><td rowspan=1 colspan=1>MeanBias</td><td rowspan=1 colspan=1>Mean%Bias</td><td rowspan=1 colspan=1>SD ofMean% Bias</td><td rowspan=1 colspan=1>AbsoluteValueofxTotalError</td></tr><tr><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>0.9997</td><td rowspan=1 colspan=1>1.01</td><td rowspan=1 colspan=1>{1.01,1.02)</td><td rowspan=1 colspan=1>.2.46</td><td rowspan=1 colspan=1>(-3.20,-1.72)</td><td rowspan=1 colspan=1>1.01</td><td rowspan=1 colspan=1>(1.00,1.02)</td><td rowspan=1 colspan=1>.2.51</td><td rowspan=1 colspan=1>(-3.42,-1.59)</td><td rowspan=1 colspan=1>1.01</td><td rowspan=1 colspan=1>(1.01,1.02)</td><td rowspan=1 colspan=1>-2.61</td><td rowspan=1 colspan=1>(-3.82,-1.74)</td><td rowspan=1 colspan=1>-0.87</td><td rowspan=1 colspan=1>-0.7</td><td rowspan=1 colspan=1>0.74</td><td rowspan=1 colspan=1>2.2</td></tr></table>

# Conclusion:

The data demonstrate that the performance of an ARCHITECT $\mathtt { c 8 0 0 0 }$ integrated with a FlexLab $3 . 6 \ : \mathrm { L A S }$ and an ARCHITECT $\mathtt { c 8 0 0 0 }$ integrated with an ACCELERATOR APS LAS are substantial equivalent.

Inpeco, S.p.a.   
$\mathbf { c / o }$ Roberto Tamborra   
11Via Giuseppe Di Vittorio Segrate, Milan, 20090   
Italy

Re: k121012 Trade Name: FlexLab 3.6 Regulation Number: 21 CFR §862.1600 Regulation Name: Potassium test system Regulatory Class: Class II Product Codes: CEM, CGZ, JGS, JJE, JQP Dated: August 31, 2012 Received: August 31, 2012

Dear Mr. Tamborra:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling. and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class II (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and isting (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820).

Page 2

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796-5450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at (301) 796-5760. For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/Medical   
Devices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance...

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-5680 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm

Sincerely yours,

2

Couptney H. Lias, Ph.D.   
Dir€ctor   
Division of Chemistry and Toxicology Devices Office of In Vitro Diagnostic Device   
Evaluation and Safety   
Center for Devices and Radiological Health

Enclosure

# Indications for use statement

510(k) Number (if known): k121012

Device Name: FlexLab 3.6

# Indications for Use:

The FlexLab 3.6 Automation is a modular system designed to automate PreAnalytical and Post-Analytical processing, sample handling in order to automate sample processing in the Laboratory.

The system consolidates analytical instruments, such as the ARCHITECT c8000 System into a unified workstation that performs a variety of instrument specific assays such as Sodium, Potassium and Chloride.

Sodium, Potassium and Chloride measurements are used in the diagnosis and treatment of diseases involving electrolyte imbalance.